WASHINGTON – The U.S. Supreme Court (search) declined to loosen the standard for proving securities fraud, ruling Tuesday that investors must show a clear link between the alleged fraud and a drop in stock price to proceed with their lawsuits. In a unanimous decision, justices sided with Dura Pharmaceuticals Inc. …
Read More »